Current Alzheimer Research
Volume 16, 14 Issues, 2019
ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)
This journal supports open access
ISSN: 1875-5828 (Online)
ISSN: 1567-2050 (Print)
This journal supports open access
Ranking and Category
-
66th of 199 in
Clinical Neurology
-
115th of 267 in
Neurosciences
Contents
Current Alzheimer Research, Volume 10 - Number 7
BACE1 Levels Correlate with Phospho-Tau Levels in Human Cerebrospinal Fluid
, 10(7): 671 - 678Soraia Barao, Lujia Zhou, Katarzyna Adamczuk, Tine Vanhoutvin, Fred van Leuven, David Demedts, Anne-Catherine Vijverman, Xavier Bossuyt, Rik Vandenberghe and Bart De Strooper
DOI: 10.2174/15672050113109990138
A High-Throughput Screening Assay for Determining Cellular Levels of Total Tau Protein
, 10(7): 679 - 687Seameen J. Dehdashti, Wei Zheng, Joel R. Gever, Robert Wilhelm, Dac-Trung Nguyen, Gurusingham Sittampalam, John C. McKew, Christopher P. Austin and Stanley B. Prusiner
DOI: 10.2174/15672050113109990143
Denervation of the Olfactory Bulb Leads to Decreased Aβ Plaque Load in a Transgenic Mouse Model of Alzheimer’ s Disease
, 10(7): 688 - 696OIivier Bibari, Siak Lee, Tracey C. Dickson, Stan Mitew, James C. Vickers and Meng I. Chuah
DOI: 10.2174/15672050113109990147
Modulation of Rack-1/PKCβII Signalling By Soluble AβPPα in SH-SY5Y Cells
, 10(7): 697 - 705Erica Buoso, Fabrizio Biundo, Cristina Lanni, Stefania Aiello, Serena Grossi, Gennaro Schettini, Stefano Govoni and Marco Racchi
DOI: 10.2174/15672050113109990145
Distinct Roles of sAPP-α and sAPP-β in Regulating U251 Cell Differentiation
, 10(7): 706 - 713Junfeng Jiang, Yue Wang, Lei Hou, Lixing Fan, Qiaoling Wang, Zhenyu Xu, Qing Sun and Houqi Liu
DOI: 10.2174/15672050113109990141
The Impact of AD Drug Treatments on Event-Related Potentials as Markers of Disease Conversion
, 10(7): 732 - 741Robert M. Chapman, Anton P. Porsteinsson, Margaret N. Gardner, Mark Mapstone, John W. McCrary, Tiffany C. Sandoval, Maria D. Guillily, Lindsey A. Reilly and Elizabeth DeGrush
DOI: 10.2174/15672050113109990148
CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo- Controlled Study
, 10(7): 742 - 753Joel Ross, Sanjiv Sharma, Jaron Winston, Margarita Nunez, Gabriella Bottini, Massimo Franceschi, Elio Scarpini, Enrico Frigerio, Francesco Fiorentini, Mercedes Fernandez, Sandra Sivilia, Luciana Giardino, Laura Calza, Dottie Norris, Helen Cicirello, Daniela Casula and Bruno P. Imbimbo
DOI: 10.2174/13892037113149990144
Impaired Functional Connectivity of the Thalamus in Alzheimer’ s Disease and Mild Cognitive Impairment: A Resting-State fMRI Study
, 10(7): 754 - 766Bo Zhou, Yong Liu, Zengqiang Zhang, Ningyu An, Hongxiang Yao, Pan Wang, Luning Wang, Xi Zhang and Tianzi Jiang
DOI: 10.2174/15672050113109990146
Sleep Disturbance is Associated with Incident Dementia and Mortality
, 10(7): 767 - 775Roxanne Sterniczuk, Olga Theou, Benjamin Rusak and Kenneth Rockwood
DOI: 10.2174/15672050113109990134
Quality of Education and Memory Test Performance in Older Men: The New York University Paragraph Recall Test Normative Data
, 10(7): 776 - 783Melissa Mathews, Erin Abner, Allison Caban-Holt, Brandon C. Dennis, Richard Kryscio and Frederick Schmitt
DOI: 10.2174/15672050113109990140
  |
Editor-in-Chief
Prof. Debomoy K. Lahiri
(15455 citations)
Neuroscience Research Center
Indianapolis, IN 46202
USA
Biography
View Full Editorial Board
(15455 citations)
Neuroscience Research Center
Indianapolis, IN 46202
USA
Biography
Biography of Debomoy K. Lahiri
Dr. Debomoy Lahiri is Professor at Indiana University School of Medicine, USA. His major research focus is to understand the mechanism of aging, origin and biogenesis of the amyloid plaque, and to discover drug targets for Alzheimer's disease (AD) and other brain disorders. Dr. Lahiri’s group has shown the novel role of specific microRNA species in regulation of genes implicated in AD as well as the role of gene and environment interaction in late-life disorders. Also, his team has made significant contributions to understanding the biochemical pathway for neurodevelopment disorders, such as autism and fragile X syndrome. Dr. Lahiri is the Editor-In-Chief of the international journal, ‘Current Alzheimer Research' (Bentham). He authored books, such as ‘Protective Strategies for Neurodegenerative Diseases' published by the New York Academy of Sciences. Dr. Lahiri was awarded grants as a Principal Investigator from the National Institute on Aging, NIH, and Alzheimer’s Association, USA. His other honors include the ‘Zenith Award’ and listing in Marquis' ‘Who's Who in the World'.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Alzheimer Research was introduced in 2004 with the assistance of Dr. Debomoy K. Lahiri, who is the current Editor-in-Chief serving since 2004.
Scopus CiteScore Metrics: 1.43
New eBook
 |
Frontiers in Clinical Drug Research – Alzheimer DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net